Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Stephan Leucht"'
Autor:
Stephan Leucht, Irina Zaidman, Kaleem Ashraf, Adam Gassas, Muhammad Muddassir Ali, Tal Schechter, Joerg Krueger, John Doyle
Publikováno v:
Pediatric Blood & Cancer. 62:517-521
Background It is rare for infants, who are less than 365 days old, to receive hematopoietic stem cell transplantation (HSCT). Our objective was to review the indications, survival, and late effects of infants who received HSCT. Procedure Between Apri
Autor:
Ute Bartels, Tal Schechter, Eric Bouffet, Annie Huang, Tilman Humpl, John Doyle, Adam Gassas, Stephan Leucht, Ernest Cutz
Publikováno v:
Biology of Blood and Marrow Transplantation. 19:235-239
Tandem cycles of high-dose chemotherapy are an increasingly being used as alternative to radiation treatment in the management of infants and young children with central nervous system (CNS) tumors. Most of these protocols have a carboplatinum and th
Autor:
Paola Dazzan, Andreas Meyer-Lindenberg, Dan Rujescu, Stephan Leucht, Inge Winter, Silvana Galderisi, Iris E. C. Sommer, Birte Glenthøj, Celso Arango, René S. Kahn, W. Wolfgang Fleischacker, Philip McGuire
Publikováno v:
Schizophrenia Bulletin, 41(3), 574. Oxford University Press
Magnetic Resonance Imaging (MRI) measures are promising outcome markers for schizophrenia, since regional frontal and temporal grey matter volumes reductions, and enlargement of the ventricles, have been associated with outcome in this disorder. Howe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d276545cc5e3381db32b95f3bdbc976
https://europepmc.org/articles/PMC4393706/
https://europepmc.org/articles/PMC4393706/
Autor:
Adam, Gassas, Kaleem, Ashraf, Irina, Zaidman, Muhammad, Ali, Joerg, Krueger, John, Doyle, Tal, Schechter, Stephan, Leucht
Publikováno v:
Pediatric bloodcancer. 62(3)
It is rare for infants, who are less than 365 days old, to receive hematopoietic stem cell transplantation (HSCT). Our objective was to review the indications, survival, and late effects of infants who received HSCT.Between April 1992 and March 2010,
Publikováno v:
Clinical Immunology. 99:18-29
The etiology of Kawasaki disease (KD) is still unknown. Therefore, the diagnosis relies on clinical criteria only. Although a specific therapy for KD is not available, coronary complications can be significantly reduced with the help of intravenous i
Publikováno v:
Schizophrenia, Third Edition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::baed9fbc59eefd7e64cbbb8b177a2d29
https://doi.org/10.1002/9781444327298.ch26
https://doi.org/10.1002/9781444327298.ch26
Publikováno v:
Pediatric Research. 53:160-160
The etiology of Kawasaki disease (KD) is still unknown, but an infectious origin and involvement of IgA B cells has been suggested. Coronary complications of KD can be reduced with IVIG therapy. It is not clear how IVIG interacts with the immune syst